ACCEPT SIMS AI™ · BloomShield CIC

BloomShield-branded research demonstrator

RESEARCH DEMONSTRATOR — SYNTHETIC DATA ONLY — NOT FOR CLINICAL USE

Synthetic-data research demonstration · Mock mode — simulated responses, no live AI · Not for clinical use.

Integrated demonstration

Synthetic data only · Not for clinical use. Administrative decisions never establish diagnostic completion.

Load EXP-0885 · Site E · 15 November 2026

Load the fixed scenario above to follow the demonstration. Other filters and dates retain their own historical context.

Which intelligence is being demonstrated?
  • Model A: trained referral-time prediction evaluated on synthetic data, with a 60-day horizon and historical-cutoff safeguards.
  • Event-triggered review: deterministic navigation intelligence based on documented events; no new probability.
  • Generative AI: model-generated administrative recommendations in safeguarded Live mode. Mock mode uses a deterministic fixture and makes no model call.
  • Model B: proposed future dynamic prediction, not yet trained or implemented; no probability is available.
Uploads

Planned ingestion capabilities — not yet operational. This demonstration uses a fixed synthetic cohort.

  • Direct entry with mobile-friendly forms and future offline capabilities.
  • Validated CSV/Excel imports with schema, chronology and data-quality checks.
  • Secure integrations with existing records, laboratory and appointment systems, potentially using HL7 FHIR.

Programme dashboard

Screening activity and follow-up across the synthetic programme.

Site
Screening modality

Programme activity

Unique participants screened
4,325
Screening encounters
5,215
Diagnostic referrals
999
Outstanding pathways
332

Screening pathway

  1. Screening5,215Encounters
  2. Positive finding1,814Documented findings
  3. Referral999Diagnostic referrals
  4. Follow-up1,211Diagnostic visits
  5. Outcome667Resolved pathways

Stage totals use different units. Pending pathways: 332. Insufficient observation: 0.

Participant insight

Expanded synthetic participant 0137 · EXP-0137Synthetic · Site C

Full participant history through 2027-03-12, across modalities and pathways.

  1. · Screening · VIA · Initial · Programme entry
  2. · Screening result · VIA · VIA positive · Adequate
  3. · Repeat plan · HPV DNA · Prior VIA positive · Scheduled for 2026-04-28
  4. · Diagnostic referral · EXP-0137-T-R
  5. · Contact attempt · Reached
  6. · Diagnostic booking · Initial booking
  7. · Barrier documented · Appointment coordination
  8. · Navigation intervention · Coordination support
  9. · Diagnostic visit · Missed
  10. · Diagnostic booking · Rebooking
  11. · Diagnostic visit · Attended
  12. · Diagnosis · Colposcopy · Biopsy collected
  13. · Diagnosis · Histopathology · High-grade lesion
  14. · Follow-up disposition · Resolved · EXP-0137-T-R
  15. · Treatment · Synthetic precancer treatment
  16. · Surveillance plan · HPV DNA · After treatment · Scheduled for 2027-04-03
  17. · Screening · HPV DNA · Repeat · Prior VIA positive
  18. · Screening result · HPV DNA · HPV detected · Adequate

Referral-time risk

Pathway status at observation · Resolved

Loading prediction…

Observed day-60 outcome · Unresolved

Screened participants

4325 matching participants. Select a participant to review their timeline and referral-time risk.

ParticipantSite
EXP-0085 · Expanded synthetic participant 0085Site E — Resource-Constrained Navigation Programme
EXP-0086 · Expanded synthetic participant 0086Site E — Resource-Constrained Navigation Programme
EXP-0089 · Expanded synthetic participant 0089Site C — Rural Outreach Programme
EXP-0090 · Expanded synthetic participant 0090Site A — Urban Referral Hub
EXP-0091 · Expanded synthetic participant 0091Site C — Rural Outreach Programme
EXP-0092 · Expanded synthetic participant 0092Site C — Rural Outreach Programme
EXP-0093 · Expanded synthetic participant 0093Site B — Peri-Urban Access Programme
EXP-0094 · Expanded synthetic participant 0094Site A — Urban Referral Hub
EXP-0095 · Expanded synthetic participant 0095Site D — Community Engagement Programme
EXP-0096 · Expanded synthetic participant 0096Site E — Resource-Constrained Navigation Programme
EXP-0097 · Expanded synthetic participant 0097Site E — Resource-Constrained Navigation Programme
EXP-0098 · Expanded synthetic participant 0098Site A — Urban Referral Hub
EXP-0099 · Expanded synthetic participant 0099Site C — Rural Outreach Programme
EXP-0100 · Expanded synthetic participant 0100Site D — Community Engagement Programme
EXP-0101 · Expanded synthetic participant 0101Site C — Rural Outreach Programme
EXP-0102 · Expanded synthetic participant 0102Site A — Urban Referral Hub
EXP-0103 · Expanded synthetic participant 0103Site D — Community Engagement Programme
EXP-0104 · Expanded synthetic participant 0104Site A — Urban Referral Hub
EXP-0106 · Expanded synthetic participant 0106Site D — Community Engagement Programme
EXP-0107 · Expanded synthetic participant 0107Site E — Resource-Constrained Navigation Programme
EXP-0108 · Expanded synthetic participant 0108Site B — Peri-Urban Access Programme
EXP-0109 · Expanded synthetic participant 0109Site D — Community Engagement Programme
EXP-0110 · Expanded synthetic participant 0110Site A — Urban Referral Hub
EXP-0111 · Expanded synthetic participant 0111Site E — Resource-Constrained Navigation Programme
EXP-0112 · Expanded synthetic participant 0112Site A — Urban Referral Hub

Programme insights

Encounters by modality

VIA
1957
HPV DNA
2539
Cytology
719

Navigation activity

Barrier documented
907
Contact attempt
1458
Navigation intervention
397
Diagnostic booking
1256
Diagnostic visit
1211

Documented barriers

Contact difficulty
291
Transport difficulty
299
Appointment coordination
317

Site and modality select screening encounters. Pathway status limits the screened group to participants with a matching referral. Referral, navigation and barrier totals count events linked to matching pathways.